Cote d’Ivoire

A snapshot of PrEP scale-up, registration and resources for Cote D'Ivoire.

  • 100-300
    Estimated Number of Current PrEP Users

    Aggregates numbers reported from demonstration projects, PEPFAR dashboard and program/country reports where available. This is presented as a range due to difficulty in tracking precise numbers and possible double reporting.

  • 0-200
    Aggregate Target Number of PrEP Users from All Projects (Planned & Ongoing)

    Sum of the targets available at the quarterly data review. National targets put forward by governments may be aspirational and/or indicative of estimated need; or they may be low or non-existent if PrEP is solely available via demonstration projects. For this reason, a calculation of current PrEP users as a percentage of aggregate target will not accurately reflect progress. Additionally, some programs set targets on an annual basis while targets from other programs may extend over multiple years.

Data Updated: April 16, 2018

Drug Registration Status

  • Gilead's Truvada (TDF/FTC) registration
    Not submitted
  • Generic versions of TDF/FTC for prevention
    Under review

Types of Projects

  • Large-scale implementation initiative — funded/implementer involvement and investment in some or all steps related to comprehensive introduction that may or may not use government clinics as the primary service delivery point – e.g., Kenya’s Jilinde program.
  • Demonstration projects, which road-test the use of new options in real-world settings—not in a trial site. They have a formal evaluation component that is designed to address specific elements of introduction such as infrastructure needs and ways individuals can integrate it into daily activities.

Research, Demonstration and Implementation Projects

Funding

  • ANRS
  • PEPFAR
  • Expertise France

Resources for Cote d’Ivoire